nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—ABCC10—Methotrexate—ankylosing spondylitis	0.0748	0.0952	CbGbCtD
Paclitaxel—CYP19A1—Betamethasone—ankylosing spondylitis	0.0705	0.0897	CbGbCtD
Paclitaxel—ABCC2—Sulfasalazine—ankylosing spondylitis	0.0533	0.0678	CbGbCtD
Paclitaxel—ABCB11—Dexamethasone—ankylosing spondylitis	0.0506	0.0644	CbGbCtD
Paclitaxel—CYP1B1—Dexamethasone—ankylosing spondylitis	0.0506	0.0644	CbGbCtD
Paclitaxel—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0482	0.0613	CbGbCtD
Paclitaxel—SLCO1B3—Methotrexate—ankylosing spondylitis	0.0418	0.0531	CbGbCtD
Paclitaxel—CYP19A1—Dexamethasone—ankylosing spondylitis	0.041	0.0522	CbGbCtD
Paclitaxel—ABCC1—Methotrexate—ankylosing spondylitis	0.0289	0.0367	CbGbCtD
Paclitaxel—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0267	0.034	CbGbCtD
Paclitaxel—ABCC2—Dexamethasone—ankylosing spondylitis	0.0266	0.0338	CbGbCtD
Paclitaxel—ABCG2—Dexamethasone—ankylosing spondylitis	0.0241	0.0306	CbGbCtD
Paclitaxel—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0229	0.0292	CbGbCtD
Paclitaxel—ABCC2—Methotrexate—ankylosing spondylitis	0.0214	0.0272	CbGbCtD
Paclitaxel—ABCG2—Methotrexate—ankylosing spondylitis	0.0193	0.0246	CbGbCtD
Paclitaxel—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0178	0.0226	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0178	0.0226	CbGbCtD
Paclitaxel—ABCB1—Betamethasone—ankylosing spondylitis	0.0149	0.019	CbGbCtD
Paclitaxel—ABCB1—Prednisolone—ankylosing spondylitis	0.0147	0.0187	CbGbCtD
Paclitaxel—ABCB1—Prednisone—ankylosing spondylitis	0.0139	0.0177	CbGbCtD
Paclitaxel—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0137	0.0175	CbGbCtD
Paclitaxel—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0133	0.017	CbGbCtD
Paclitaxel—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0128	0.0163	CbGbCtD
Paclitaxel—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0104	0.0132	CbGbCtD
Paclitaxel—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00894	0.0114	CbGbCtD
Paclitaxel—CYP3A4—Betamethasone—ankylosing spondylitis	0.00894	0.0114	CbGbCtD
Paclitaxel—CYP3A4—Prednisolone—ankylosing spondylitis	0.00882	0.0112	CbGbCtD
Paclitaxel—ABCB1—Dexamethasone—ankylosing spondylitis	0.00867	0.011	CbGbCtD
Paclitaxel—CYP3A4—Prednisone—ankylosing spondylitis	0.00833	0.0106	CbGbCtD
Paclitaxel—ABCB1—Methotrexate—ankylosing spondylitis	0.00697	0.00887	CbGbCtD
Paclitaxel—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0052	0.00661	CbGbCtD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—CREG1—ankylosing spondylitis	0.00132	0.045	CbGpPWpGaD
Paclitaxel—TUBB6—Orphan transporters—ANO6—ankylosing spondylitis	0.00132	0.0449	CbGpPWpGaD
Paclitaxel—TUBB2B—Orphan transporters—ANO6—ankylosing spondylitis	0.00132	0.0449	CbGpPWpGaD
Paclitaxel—TUBB3—Orphan transporters—ANO6—ankylosing spondylitis	0.00128	0.0434	CbGpPWpGaD
Paclitaxel—TUBB2A—Orphan transporters—ANO6—ankylosing spondylitis	0.00124	0.042	CbGpPWpGaD
Paclitaxel—TUBB1—Orphan transporters—ANO6—ankylosing spondylitis	0.00121	0.0411	CbGpPWpGaD
Paclitaxel—TUBB4A—Orphan transporters—ANO6—ankylosing spondylitis	0.00108	0.0369	CbGpPWpGaD
Paclitaxel—TUBB4B—Orphan transporters—ANO6—ankylosing spondylitis	0.000992	0.0337	CbGpPWpGaD
Paclitaxel—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CARD9—ankylosing spondylitis	0.000953	0.0324	CbGpPWpGaD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.00088	0.0299	CbGpPWpGaD
Paclitaxel—TUBB8—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000719	0.0244	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis Modulation and Signaling—IL1R2—ankylosing spondylitis	0.000681	0.0232	CbGpPWpGaD
Paclitaxel—BCL2—Overview of nanoparticle effects—CRP—ankylosing spondylitis	0.000678	0.0231	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—IL1R2—ankylosing spondylitis	0.000678	0.0231	CbGpPWpGaD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.000607	0.0206	CbGpPWpGaD
Paclitaxel—ABCC10—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00051	0.0173	CbGpPWpGaD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.000437	0.0149	CbGpPWpGaD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.000434	0.0148	CbGpPWpGaD
Paclitaxel—BCL2—FAS pathway and Stress induction of HSP regulation—IL1A—ankylosing spondylitis	0.00043	0.0146	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TNFRSF1B—ankylosing spondylitis	0.000406	0.0138	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis Modulation and Signaling—TNFRSF1B—ankylosing spondylitis	0.00038	0.0129	CbGpPWpGaD
Paclitaxel—TUBB2B—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000363	0.0124	CbGpPWpGaD
Paclitaxel—TUBB6—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000363	0.0124	CbGpPWpGaD
Paclitaxel—TUBB—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.00036	0.0123	CbGpPWpGaD
Paclitaxel—TUBB3—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000351	0.0119	CbGpPWpGaD
Paclitaxel—TUBB2A—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.00034	0.0116	CbGpPWpGaD
Paclitaxel—TUBB1—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000332	0.0113	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.00033	0.0112	CbGpPWpGaD
Paclitaxel—TUBB2B—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000322	0.011	CbGpPWpGaD
Paclitaxel—TUBB6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000322	0.011	CbGpPWpGaD
Paclitaxel—TUBB3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000311	0.0106	CbGpPWpGaD
Paclitaxel—BCL2—Overview of nanoparticle effects—TNF—ankylosing spondylitis	0.000307	0.0104	CbGpPWpGaD
Paclitaxel—TUBB2A—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000302	0.0103	CbGpPWpGaD
Paclitaxel—TUBB4A—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000298	0.0102	CbGpPWpGaD
Paclitaxel—TUBB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000295	0.01	CbGpPWpGaD
Paclitaxel—TUBB4B—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000273	0.00928	CbGpPWpGaD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000265	0.00901	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000242	0.00824	CbGpPWpGaD
Paclitaxel—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TNF—ankylosing spondylitis	0.000239	0.00813	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.000231	0.00785	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000219	0.00744	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—IL1A—ankylosing spondylitis	0.000207	0.00703	CbGpPWpGaD
Paclitaxel—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—ankylosing spondylitis	0.000197	0.00672	CbGpPWpGaD
Paclitaxel—BCL2—Corticotropin-releasing hormone—TLR4—ankylosing spondylitis	0.000184	0.00626	CbGpPWpGaD
Paclitaxel—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—ankylosing spondylitis	0.000176	0.006	CbGpPWpGaD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.000165	0.00562	CbGpPWpGaD
Paclitaxel—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—ankylosing spondylitis	0.000163	0.00554	CbGpPWpGaD
Paclitaxel—MAPT—Alzheimers Disease—TNF—ankylosing spondylitis	0.00016	0.00543	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000156	0.00532	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000155	0.00526	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—KIR3DL1—ankylosing spondylitis	0.000149	0.00508	CbGpPWpGaD
Paclitaxel—BCL2—Ceramide signaling pathway—TNF—ankylosing spondylitis	0.000146	0.00498	CbGpPWpGaD
Paclitaxel—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000146	0.000791	CcSEcCtD
Paclitaxel—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000146	0.00079	CcSEcCtD
Paclitaxel—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000145	0.000789	CcSEcCtD
Paclitaxel—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000145	0.000789	CcSEcCtD
Paclitaxel—Epistaxis—Methotrexate—ankylosing spondylitis	0.000145	0.000788	CcSEcCtD
Paclitaxel—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000145	0.000788	CcSEcCtD
Paclitaxel—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000145	0.000788	CcSEcCtD
Paclitaxel—Mental disorder—Prednisone—ankylosing spondylitis	0.000145	0.000787	CcSEcCtD
Paclitaxel—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000145	0.000786	CcSEcCtD
Paclitaxel—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000144	0.000782	CcSEcCtD
Paclitaxel—Erythema—Prednisone—ankylosing spondylitis	0.000144	0.000782	CcSEcCtD
Paclitaxel—Malnutrition—Prednisone—ankylosing spondylitis	0.000144	0.000782	CcSEcCtD
Paclitaxel—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000144	0.00078	CcSEcCtD
Paclitaxel—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000144	0.000779	CcSEcCtD
Paclitaxel—Convulsion—Betamethasone—ankylosing spondylitis	0.000143	0.000778	CcSEcCtD
Paclitaxel—Convulsion—Dexamethasone—ankylosing spondylitis	0.000143	0.000778	CcSEcCtD
Paclitaxel—Hypertension—Betamethasone—ankylosing spondylitis	0.000143	0.000775	CcSEcCtD
Paclitaxel—Hypertension—Dexamethasone—ankylosing spondylitis	0.000143	0.000775	CcSEcCtD
Paclitaxel—Myalgia—Dexamethasone—ankylosing spondylitis	0.000141	0.000764	CcSEcCtD
Paclitaxel—Myalgia—Betamethasone—ankylosing spondylitis	0.000141	0.000764	CcSEcCtD
Paclitaxel—Anxiety—Dexamethasone—ankylosing spondylitis	0.00014	0.000761	CcSEcCtD
Paclitaxel—Anxiety—Betamethasone—ankylosing spondylitis	0.00014	0.000761	CcSEcCtD
Paclitaxel—Discomfort—Dexamethasone—ankylosing spondylitis	0.000139	0.000755	CcSEcCtD
Paclitaxel—Discomfort—Betamethasone—ankylosing spondylitis	0.000139	0.000755	CcSEcCtD
Paclitaxel—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000139	0.000754	CcSEcCtD
Paclitaxel—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000139	0.000753	CcSEcCtD
Paclitaxel—Pain—Prednisolone—ankylosing spondylitis	0.000138	0.000751	CcSEcCtD
Paclitaxel—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000138	0.00075	CcSEcCtD
Paclitaxel—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000137	0.000745	CcSEcCtD
Paclitaxel—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000137	0.000741	CcSEcCtD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000136	0.00463	CbGpPWpGaD
Paclitaxel—Vision blurred—Prednisone—ankylosing spondylitis	0.000136	0.000737	CcSEcCtD
Paclitaxel—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000136	0.000736	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000136	0.000735	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000135	0.000734	CcSEcCtD
Paclitaxel—Oedema—Dexamethasone—ankylosing spondylitis	0.000135	0.000732	CcSEcCtD
Paclitaxel—Oedema—Betamethasone—ankylosing spondylitis	0.000135	0.000732	CcSEcCtD
Paclitaxel—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000135	0.000732	CcSEcCtD
Paclitaxel—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000135	0.000732	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—CARD9—ankylosing spondylitis	0.000135	0.00458	CbGpPWpGaD
Paclitaxel—Insomnia—Triamcinolone—ankylosing spondylitis	0.000135	0.00073	CcSEcCtD
Paclitaxel—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000134	0.000729	CcSEcCtD
Paclitaxel—Infection—Betamethasone—ankylosing spondylitis	0.000134	0.000728	CcSEcCtD
Paclitaxel—Infection—Dexamethasone—ankylosing spondylitis	0.000134	0.000728	CcSEcCtD
Paclitaxel—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000134	0.000725	CcSEcCtD
Paclitaxel—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000134	0.000725	CcSEcCtD
Paclitaxel—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000133	0.000723	CcSEcCtD
Paclitaxel—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000133	0.000723	CcSEcCtD
Paclitaxel—Visual impairment—Methotrexate—ankylosing spondylitis	0.000133	0.000723	CcSEcCtD
Paclitaxel—Anaemia—Prednisone—ankylosing spondylitis	0.000133	0.000722	CcSEcCtD
Paclitaxel—Shock—Betamethasone—ankylosing spondylitis	0.000133	0.000721	CcSEcCtD
Paclitaxel—Shock—Dexamethasone—ankylosing spondylitis	0.000133	0.000721	CcSEcCtD
Paclitaxel—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000133	0.00072	CcSEcCtD
Paclitaxel—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000132	0.000718	CcSEcCtD
Paclitaxel—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000132	0.000718	CcSEcCtD
Paclitaxel—Agitation—Prednisone—ankylosing spondylitis	0.000132	0.000718	CcSEcCtD
Paclitaxel—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000132	0.000717	CcSEcCtD
Paclitaxel—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000132	0.000717	CcSEcCtD
Paclitaxel—Tachycardia—Betamethasone—ankylosing spondylitis	0.000132	0.000715	CcSEcCtD
Paclitaxel—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000132	0.000715	CcSEcCtD
Paclitaxel—Angioedema—Prednisone—ankylosing spondylitis	0.000132	0.000714	CcSEcCtD
Paclitaxel—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000131	0.000711	CcSEcCtD
Paclitaxel—TUBB2B—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000131	0.00445	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000131	0.00445	CbGpPWpGaD
Paclitaxel—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000131	0.000709	CcSEcCtD
Paclitaxel—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000131	0.000709	CcSEcCtD
Paclitaxel—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000131	0.000708	CcSEcCtD
Paclitaxel—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000131	0.000708	CcSEcCtD
Paclitaxel—Malaise—Prednisone—ankylosing spondylitis	0.00013	0.000705	CcSEcCtD
Paclitaxel—Vertigo—Prednisone—ankylosing spondylitis	0.000129	0.000702	CcSEcCtD
Paclitaxel—Eye disorder—Methotrexate—ankylosing spondylitis	0.000129	0.000701	CcSEcCtD
Paclitaxel—Syncope—Prednisone—ankylosing spondylitis	0.000129	0.000701	CcSEcCtD
Paclitaxel—Tinnitus—Methotrexate—ankylosing spondylitis	0.000129	0.0007	CcSEcCtD
Paclitaxel—Anorexia—Dexamethasone—ankylosing spondylitis	0.000129	0.000698	CcSEcCtD
Paclitaxel—Anorexia—Betamethasone—ankylosing spondylitis	0.000129	0.000698	CcSEcCtD
Paclitaxel—Urticaria—Prednisolone—ankylosing spondylitis	0.000129	0.000697	CcSEcCtD
Paclitaxel—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000128	0.000696	CcSEcCtD
Paclitaxel—Fatigue—Triamcinolone—ankylosing spondylitis	0.000128	0.000696	CcSEcCtD
Paclitaxel—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000128	0.000694	CcSEcCtD
Paclitaxel—BCL2—Caspase Cascade in Apoptosis—TNF—ankylosing spondylitis	0.000128	0.00434	CbGpPWpGaD
Paclitaxel—Pain—Triamcinolone—ankylosing spondylitis	0.000127	0.00069	CcSEcCtD
Paclitaxel—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000127	0.000687	CcSEcCtD
Paclitaxel—TUBB3—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000126	0.0043	CbGpPWpGaD
Paclitaxel—Hypotension—Betamethasone—ankylosing spondylitis	0.000126	0.000684	CcSEcCtD
Paclitaxel—Hypotension—Dexamethasone—ankylosing spondylitis	0.000126	0.000684	CcSEcCtD
Paclitaxel—Angiopathy—Methotrexate—ankylosing spondylitis	0.000125	0.000681	CcSEcCtD
Paclitaxel—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000125	0.000678	CcSEcCtD
Paclitaxel—Convulsion—Prednisone—ankylosing spondylitis	0.000125	0.000677	CcSEcCtD
Paclitaxel—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000125	0.000676	CcSEcCtD
Paclitaxel—Hypertension—Prednisone—ankylosing spondylitis	0.000124	0.000675	CcSEcCtD
Paclitaxel—Chills—Methotrexate—ankylosing spondylitis	0.000124	0.000673	CcSEcCtD
Paclitaxel—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000124	0.00421	CbGpPWpGaD
Paclitaxel—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000123	0.000667	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000123	0.000667	CcSEcCtD
Paclitaxel—Myalgia—Prednisone—ankylosing spondylitis	0.000123	0.000665	CcSEcCtD
Paclitaxel—Arthralgia—Prednisone—ankylosing spondylitis	0.000123	0.000665	CcSEcCtD
Paclitaxel—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000123	0.000665	CcSEcCtD
Paclitaxel—TUBB2A—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000122	0.00416	CbGpPWpGaD
Paclitaxel—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000122	0.000664	CcSEcCtD
Paclitaxel—Anxiety—Prednisone—ankylosing spondylitis	0.000122	0.000663	CcSEcCtD
Paclitaxel—Alopecia—Methotrexate—ankylosing spondylitis	0.000122	0.000663	CcSEcCtD
Paclitaxel—Insomnia—Dexamethasone—ankylosing spondylitis	0.000122	0.000663	CcSEcCtD
Paclitaxel—Insomnia—Betamethasone—ankylosing spondylitis	0.000122	0.000663	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000122	0.000661	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000121	0.000659	CcSEcCtD
Paclitaxel—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000121	0.000658	CcSEcCtD
Paclitaxel—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000121	0.000658	CcSEcCtD
Paclitaxel—Discomfort—Prednisone—ankylosing spondylitis	0.000121	0.000657	CcSEcCtD
Paclitaxel—Mental disorder—Methotrexate—ankylosing spondylitis	0.000121	0.000657	CcSEcCtD
Paclitaxel—Malnutrition—Methotrexate—ankylosing spondylitis	0.00012	0.000653	CcSEcCtD
Paclitaxel—Erythema—Methotrexate—ankylosing spondylitis	0.00012	0.000653	CcSEcCtD
Paclitaxel—TUBB1—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.00012	0.00407	CbGpPWpGaD
Paclitaxel—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000119	0.000647	CcSEcCtD
Paclitaxel—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000119	0.000645	CcSEcCtD
Paclitaxel—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000119	0.000645	CcSEcCtD
Paclitaxel—Urticaria—Triamcinolone—ankylosing spondylitis	0.000118	0.000641	CcSEcCtD
Paclitaxel—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000118	0.00064	CcSEcCtD
Paclitaxel—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000118	0.00064	CcSEcCtD
Paclitaxel—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000118	0.000638	CcSEcCtD
Paclitaxel—Oedema—Prednisone—ankylosing spondylitis	0.000118	0.000638	CcSEcCtD
Paclitaxel—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000118	0.000638	CcSEcCtD
Paclitaxel—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000117	0.000637	CcSEcCtD
Paclitaxel—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000117	0.000637	CcSEcCtD
Paclitaxel—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000117	0.000637	CcSEcCtD
Paclitaxel—Infection—Prednisone—ankylosing spondylitis	0.000117	0.000634	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000117	0.000632	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000117	0.000632	CcSEcCtD
Paclitaxel—Back pain—Methotrexate—ankylosing spondylitis	0.000116	0.000632	CcSEcCtD
Paclitaxel—Fatigue—Dexamethasone—ankylosing spondylitis	0.000116	0.000632	CcSEcCtD
Paclitaxel—Fatigue—Betamethasone—ankylosing spondylitis	0.000116	0.000632	CcSEcCtD
Paclitaxel—Shock—Prednisone—ankylosing spondylitis	0.000116	0.000628	CcSEcCtD
Paclitaxel—Pain—Dexamethasone—ankylosing spondylitis	0.000115	0.000626	CcSEcCtD
Paclitaxel—Pain—Betamethasone—ankylosing spondylitis	0.000115	0.000626	CcSEcCtD
Paclitaxel—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000115	0.000626	CcSEcCtD
Paclitaxel—Tachycardia—Prednisone—ankylosing spondylitis	0.000115	0.000623	CcSEcCtD
Paclitaxel—Skin disorder—Prednisone—ankylosing spondylitis	0.000114	0.00062	CcSEcCtD
Paclitaxel—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000114	0.000617	CcSEcCtD
Paclitaxel—Vision blurred—Methotrexate—ankylosing spondylitis	0.000113	0.000616	CcSEcCtD
Paclitaxel—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	0.000113	0.00385	CbGpPWpGaD
Paclitaxel—Anorexia—Prednisone—ankylosing spondylitis	0.000112	0.000608	CcSEcCtD
Paclitaxel—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000112	0.000606	CcSEcCtD
Paclitaxel—Anaemia—Methotrexate—ankylosing spondylitis	0.000111	0.000604	CcSEcCtD
Paclitaxel—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000111	0.000604	CcSEcCtD
Paclitaxel—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000111	0.000604	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00011	0.000599	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00011	0.000599	CcSEcCtD
Paclitaxel—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00011	0.000595	CcSEcCtD
Paclitaxel—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000109	0.000593	CcSEcCtD
Paclitaxel—Malaise—Methotrexate—ankylosing spondylitis	0.000109	0.000589	CcSEcCtD
Paclitaxel—Vertigo—Methotrexate—ankylosing spondylitis	0.000108	0.000587	CcSEcCtD
Paclitaxel—Leukopenia—Methotrexate—ankylosing spondylitis	0.000108	0.000585	CcSEcCtD
Paclitaxel—TUBB4A—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000107	0.00366	CbGpPWpGaD
Paclitaxel—Urticaria—Dexamethasone—ankylosing spondylitis	0.000107	0.000582	CcSEcCtD
Paclitaxel—Urticaria—Betamethasone—ankylosing spondylitis	0.000107	0.000582	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000107	0.000581	CcSEcCtD
Paclitaxel—Dizziness—Prednisolone—ankylosing spondylitis	0.000107	0.00058	CcSEcCtD
Paclitaxel—Asthenia—Triamcinolone—ankylosing spondylitis	0.000107	0.000579	CcSEcCtD
Paclitaxel—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000107	0.000579	CcSEcCtD
Paclitaxel—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000107	0.000579	CcSEcCtD
Paclitaxel—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000107	0.000579	CcSEcCtD
Paclitaxel—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000107	0.000579	CcSEcCtD
Paclitaxel—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000107	0.000578	CcSEcCtD
Paclitaxel—Insomnia—Prednisone—ankylosing spondylitis	0.000106	0.000577	CcSEcCtD
Paclitaxel—Paraesthesia—Prednisone—ankylosing spondylitis	0.000106	0.000573	CcSEcCtD
Paclitaxel—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	0.000105	0.00358	CbGpPWpGaD
Paclitaxel—Pruritus—Triamcinolone—ankylosing spondylitis	0.000105	0.000571	CcSEcCtD
Paclitaxel—Cough—Methotrexate—ankylosing spondylitis	0.000105	0.00057	CcSEcCtD
Paclitaxel—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000105	0.00057	CcSEcCtD
Paclitaxel—Convulsion—Methotrexate—ankylosing spondylitis	0.000104	0.000566	CcSEcCtD
Paclitaxel—Dyspepsia—Prednisone—ankylosing spondylitis	0.000103	0.000562	CcSEcCtD
Paclitaxel—Myalgia—Methotrexate—ankylosing spondylitis	0.000102	0.000556	CcSEcCtD
Paclitaxel—Arthralgia—Methotrexate—ankylosing spondylitis	0.000102	0.000556	CcSEcCtD
Paclitaxel—Chest pain—Methotrexate—ankylosing spondylitis	0.000102	0.000556	CcSEcCtD
Paclitaxel—Decreased appetite—Prednisone—ankylosing spondylitis	0.000102	0.000555	CcSEcCtD
Paclitaxel—Rash—Prednisolone—ankylosing spondylitis	0.000102	0.000553	CcSEcCtD
Paclitaxel—Dermatitis—Prednisolone—ankylosing spondylitis	0.000102	0.000553	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000102	0.000552	CcSEcCtD
Paclitaxel—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000102	0.000551	CcSEcCtD
Paclitaxel—Fatigue—Prednisone—ankylosing spondylitis	0.000101	0.00055	CcSEcCtD
Paclitaxel—Headache—Prednisolone—ankylosing spondylitis	0.000101	0.00055	CcSEcCtD
Paclitaxel—Discomfort—Methotrexate—ankylosing spondylitis	0.000101	0.000549	CcSEcCtD
Paclitaxel—Constipation—Prednisone—ankylosing spondylitis	0.000101	0.000545	CcSEcCtD
Paclitaxel—Confusional state—Methotrexate—ankylosing spondylitis	9.91e-05	0.000538	CcSEcCtD
Paclitaxel—Dizziness—Triamcinolone—ankylosing spondylitis	9.84e-05	0.000534	CcSEcCtD
Paclitaxel—TUBB4B—Metabolism of proteins—B3GNT2—ankylosing spondylitis	9.83e-05	0.00334	CbGpPWpGaD
Paclitaxel—Anaphylactic shock—Methotrexate—ankylosing spondylitis	9.83e-05	0.000533	CcSEcCtD
Paclitaxel—Dizziness—Methylprednisolone—ankylosing spondylitis	9.82e-05	0.000533	CcSEcCtD
Paclitaxel—Infection—Methotrexate—ankylosing spondylitis	9.76e-05	0.00053	CcSEcCtD
Paclitaxel—Feeling abnormal—Prednisone—ankylosing spondylitis	9.69e-05	0.000526	CcSEcCtD
Paclitaxel—Asthenia—Betamethasone—ankylosing spondylitis	9.69e-05	0.000526	CcSEcCtD
Paclitaxel—Asthenia—Dexamethasone—ankylosing spondylitis	9.69e-05	0.000526	CcSEcCtD
Paclitaxel—Nervous system disorder—Methotrexate—ankylosing spondylitis	9.64e-05	0.000523	CcSEcCtD
Paclitaxel—Thrombocytopenia—Methotrexate—ankylosing spondylitis	9.62e-05	0.000522	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Prednisone—ankylosing spondylitis	9.61e-05	0.000522	CcSEcCtD
Paclitaxel—Nausea—Prednisolone—ankylosing spondylitis	9.61e-05	0.000521	CcSEcCtD
Paclitaxel—Pruritus—Betamethasone—ankylosing spondylitis	9.55e-05	0.000518	CcSEcCtD
Paclitaxel—Pruritus—Dexamethasone—ankylosing spondylitis	9.55e-05	0.000518	CcSEcCtD
Paclitaxel—Skin disorder—Methotrexate—ankylosing spondylitis	9.54e-05	0.000518	CcSEcCtD
Paclitaxel—Hyperhidrosis—Methotrexate—ankylosing spondylitis	9.5e-05	0.000515	CcSEcCtD
Paclitaxel—Vomiting—Triamcinolone—ankylosing spondylitis	9.46e-05	0.000513	CcSEcCtD
Paclitaxel—Vomiting—Methylprednisolone—ankylosing spondylitis	9.44e-05	0.000512	CcSEcCtD
Paclitaxel—Rash—Triamcinolone—ankylosing spondylitis	9.38e-05	0.000509	CcSEcCtD
Paclitaxel—Dermatitis—Triamcinolone—ankylosing spondylitis	9.37e-05	0.000509	CcSEcCtD
Paclitaxel—Anorexia—Methotrexate—ankylosing spondylitis	9.37e-05	0.000508	CcSEcCtD
Paclitaxel—Rash—Methylprednisolone—ankylosing spondylitis	9.36e-05	0.000508	CcSEcCtD
Paclitaxel—BCL2—Apoptosis—TNF—ankylosing spondylitis	9.35e-05	0.00318	CbGpPWpGaD
Paclitaxel—Dermatitis—Methylprednisolone—ankylosing spondylitis	9.35e-05	0.000507	CcSEcCtD
Paclitaxel—Urticaria—Prednisone—ankylosing spondylitis	9.34e-05	0.000507	CcSEcCtD
Paclitaxel—Headache—Triamcinolone—ankylosing spondylitis	9.32e-05	0.000506	CcSEcCtD
Paclitaxel—MAPT—Apoptosis—TNF—ankylosing spondylitis	9.32e-05	0.00317	CbGpPWpGaD
Paclitaxel—Headache—Methylprednisolone—ankylosing spondylitis	9.3e-05	0.000505	CcSEcCtD
Paclitaxel—Abdominal pain—Prednisone—ankylosing spondylitis	9.29e-05	0.000504	CcSEcCtD
Paclitaxel—Body temperature increased—Prednisone—ankylosing spondylitis	9.29e-05	0.000504	CcSEcCtD
Paclitaxel—Diarrhoea—Dexamethasone—ankylosing spondylitis	9.24e-05	0.000501	CcSEcCtD
Paclitaxel—Diarrhoea—Betamethasone—ankylosing spondylitis	9.24e-05	0.000501	CcSEcCtD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	9.18e-05	0.00312	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	9.18e-05	0.00312	CbGpPWpGaD
Paclitaxel—Hypotension—Methotrexate—ankylosing spondylitis	9.18e-05	0.000498	CcSEcCtD
Paclitaxel—BCL2—Immune System—IL1R2—ankylosing spondylitis	9.05e-05	0.00308	CbGpPWpGaD
Paclitaxel—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	8.95e-05	0.000486	CcSEcCtD
Paclitaxel—Dizziness—Betamethasone—ankylosing spondylitis	8.93e-05	0.000484	CcSEcCtD
Paclitaxel—Dizziness—Dexamethasone—ankylosing spondylitis	8.93e-05	0.000484	CcSEcCtD
Paclitaxel—Insomnia—Methotrexate—ankylosing spondylitis	8.89e-05	0.000482	CcSEcCtD
Paclitaxel—Nausea—Triamcinolone—ankylosing spondylitis	8.84e-05	0.00048	CcSEcCtD
Paclitaxel—Paraesthesia—Methotrexate—ankylosing spondylitis	8.82e-05	0.000479	CcSEcCtD
Paclitaxel—Nausea—Methylprednisolone—ankylosing spondylitis	8.82e-05	0.000478	CcSEcCtD
Paclitaxel—Dyspnoea—Methotrexate—ankylosing spondylitis	8.76e-05	0.000475	CcSEcCtD
Paclitaxel—MAPT—MAPK Signaling Pathway—TNF—ankylosing spondylitis	8.74e-05	0.00297	CbGpPWpGaD
Paclitaxel—Somnolence—Methotrexate—ankylosing spondylitis	8.73e-05	0.000474	CcSEcCtD
Paclitaxel—Hypersensitivity—Prednisone—ankylosing spondylitis	8.66e-05	0.00047	CcSEcCtD
Paclitaxel—Dyspepsia—Methotrexate—ankylosing spondylitis	8.65e-05	0.000469	CcSEcCtD
Paclitaxel—Vomiting—Dexamethasone—ankylosing spondylitis	8.58e-05	0.000466	CcSEcCtD
Paclitaxel—Vomiting—Betamethasone—ankylosing spondylitis	8.58e-05	0.000466	CcSEcCtD
Paclitaxel—BCL2—Immune System—ERAP1—ankylosing spondylitis	8.58e-05	0.00292	CbGpPWpGaD
Paclitaxel—Decreased appetite—Methotrexate—ankylosing spondylitis	8.54e-05	0.000463	CcSEcCtD
Paclitaxel—Rash—Betamethasone—ankylosing spondylitis	8.51e-05	0.000462	CcSEcCtD
Paclitaxel—Rash—Dexamethasone—ankylosing spondylitis	8.51e-05	0.000462	CcSEcCtD
Paclitaxel—Dermatitis—Dexamethasone—ankylosing spondylitis	8.5e-05	0.000461	CcSEcCtD
Paclitaxel—Dermatitis—Betamethasone—ankylosing spondylitis	8.5e-05	0.000461	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	8.48e-05	0.00046	CcSEcCtD
Paclitaxel—Fatigue—Methotrexate—ankylosing spondylitis	8.47e-05	0.00046	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—HLA-C—ankylosing spondylitis	8.46e-05	0.00288	CbGpPWpGaD
Paclitaxel—Headache—Betamethasone—ankylosing spondylitis	8.46e-05	0.000459	CcSEcCtD
Paclitaxel—Headache—Dexamethasone—ankylosing spondylitis	8.46e-05	0.000459	CcSEcCtD
Paclitaxel—Asthenia—Prednisone—ankylosing spondylitis	8.44e-05	0.000458	CcSEcCtD
Paclitaxel—Pain—Methotrexate—ankylosing spondylitis	8.4e-05	0.000456	CcSEcCtD
Paclitaxel—Pruritus—Prednisone—ankylosing spondylitis	8.32e-05	0.000451	CcSEcCtD
Paclitaxel—Feeling abnormal—Methotrexate—ankylosing spondylitis	8.1e-05	0.000439	CcSEcCtD
Paclitaxel—Diarrhoea—Prednisone—ankylosing spondylitis	8.04e-05	0.000436	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	8.03e-05	0.000436	CcSEcCtD
Paclitaxel—Nausea—Betamethasone—ankylosing spondylitis	8.02e-05	0.000435	CcSEcCtD
Paclitaxel—Nausea—Dexamethasone—ankylosing spondylitis	8.02e-05	0.000435	CcSEcCtD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	7.88e-05	0.00268	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CARD9—ankylosing spondylitis	7.85e-05	0.00267	CbGpPWpGaD
Paclitaxel—Urticaria—Methotrexate—ankylosing spondylitis	7.81e-05	0.000424	CcSEcCtD
Paclitaxel—Dizziness—Prednisone—ankylosing spondylitis	7.77e-05	0.000422	CcSEcCtD
Paclitaxel—Body temperature increased—Methotrexate—ankylosing spondylitis	7.77e-05	0.000421	CcSEcCtD
Paclitaxel—Abdominal pain—Methotrexate—ankylosing spondylitis	7.77e-05	0.000421	CcSEcCtD
Paclitaxel—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	7.75e-05	0.00263	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	7.7e-05	0.00262	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	7.7e-05	0.00262	CbGpPWpGaD
Paclitaxel—Vomiting—Prednisone—ankylosing spondylitis	7.48e-05	0.000406	CcSEcCtD
Paclitaxel—Rash—Prednisone—ankylosing spondylitis	7.41e-05	0.000402	CcSEcCtD
Paclitaxel—Dermatitis—Prednisone—ankylosing spondylitis	7.41e-05	0.000402	CcSEcCtD
Paclitaxel—Headache—Prednisone—ankylosing spondylitis	7.37e-05	0.0004	CcSEcCtD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	7.36e-05	0.0025	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	7.33e-05	0.00249	CbGpPWpGaD
Paclitaxel—Hypersensitivity—Methotrexate—ankylosing spondylitis	7.24e-05	0.000393	CcSEcCtD
Paclitaxel—Asthenia—Methotrexate—ankylosing spondylitis	7.05e-05	0.000382	CcSEcCtD
Paclitaxel—Nausea—Prednisone—ankylosing spondylitis	6.98e-05	0.000379	CcSEcCtD
Paclitaxel—Pruritus—Methotrexate—ankylosing spondylitis	6.95e-05	0.000377	CcSEcCtD
Paclitaxel—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	6.79e-05	0.00231	CbGpPWpGaD
Paclitaxel—Diarrhoea—Methotrexate—ankylosing spondylitis	6.72e-05	0.000365	CcSEcCtD
Paclitaxel—ABCC1—Disease—ANTXR2—ankylosing spondylitis	6.56e-05	0.00223	CbGpPWpGaD
Paclitaxel—Dizziness—Methotrexate—ankylosing spondylitis	6.5e-05	0.000353	CcSEcCtD
Paclitaxel—Vomiting—Methotrexate—ankylosing spondylitis	6.25e-05	0.000339	CcSEcCtD
Paclitaxel—Rash—Methotrexate—ankylosing spondylitis	6.2e-05	0.000336	CcSEcCtD
Paclitaxel—Dermatitis—Methotrexate—ankylosing spondylitis	6.19e-05	0.000336	CcSEcCtD
Paclitaxel—Headache—Methotrexate—ankylosing spondylitis	6.16e-05	0.000334	CcSEcCtD
Paclitaxel—Nausea—Methotrexate—ankylosing spondylitis	5.84e-05	0.000317	CcSEcCtD
Paclitaxel—BCL2—Apoptosis—TNF—ankylosing spondylitis	5.73e-05	0.00195	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—HLA-B—ankylosing spondylitis	5e-05	0.0017	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HLA-C—ankylosing spondylitis	4.93e-05	0.00168	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	4.85e-05	0.00165	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—B3GNT2—ankylosing spondylitis	4.58e-05	0.00156	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—CRP—ankylosing spondylitis	4.42e-05	0.0015	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—B3GNT2—ankylosing spondylitis	4.31e-05	0.00147	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL1RN—ankylosing spondylitis	4.28e-05	0.00146	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—TLR4—ankylosing spondylitis	4.24e-05	0.00144	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—B3GNT2—ankylosing spondylitis	3.86e-05	0.00131	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD79A—ankylosing spondylitis	3.76e-05	0.00128	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—B3GNT2—ankylosing spondylitis	3.25e-05	0.00111	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—B3GNT2—ankylosing spondylitis	3.24e-05	0.0011	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—B3GNT2—ankylosing spondylitis	3.13e-05	0.00106	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL1A—ankylosing spondylitis	3.08e-05	0.00105	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD40LG—ankylosing spondylitis	3.06e-05	0.00104	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	2.93e-05	0.000997	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HLA-B—ankylosing spondylitis	2.91e-05	0.000991	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—B3GNT2—ankylosing spondylitis	2.85e-05	0.000969	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—B3GNT2—ankylosing spondylitis	2.82e-05	0.00096	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HLA-A—ankylosing spondylitis	2.7e-05	0.000918	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CRP—ankylosing spondylitis	2.58e-05	0.000876	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—TLR4—ankylosing spondylitis	2.47e-05	0.00084	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—B3GNT2—ankylosing spondylitis	2.04e-05	0.000694	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—B3GNT2—ankylosing spondylitis	1.77e-05	0.000601	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HLA-A—ankylosing spondylitis	1.56e-05	0.000532	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	1.54e-05	0.000524	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	1.45e-05	0.000492	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—B3GNT2—ankylosing spondylitis	1.44e-05	0.000489	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	9.48e-06	0.000323	CbGpPWpGaD
